a month ago
LLY
AnalystsJason GerberryJason Gerberry's Stock Forecasts
AnalystsJason Gerberry
Analyst Ranking
Top 12%
#647 out of 5487 analysts
Average Return
+10.52%
Win Rate
56%74 out of 132
Risk vs Reward
Poor
Good
Jason Gerberry's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Liquidia CorpLQDA | +361.78% | $14.13 | $65.25 | 2025-06-11 - 2026-06-10 | Strong Buy |
Horizon Therapeutics Public Ltd CoHZNP | +246.56% | $24.87 | $86.19 | 2020-03-23 - 2021-03-23 | Strong Buy |
Liquidia CorpLQDA | +182.40% | $9.60 | $27.11 | 2024-08-20 - 2025-08-19 | Strong Buy |
Immunovant IncIMVT | +162.26% | $15.21 | $39.89 | 2025-08-12 - 2026-08-10 | Strong Buy |
Bioverativ IncBIVV | +134.78% | $44.10 | $103.54 | 2017-02-15 - 2018-02-15 | Buy |
Jason Gerberry Analyst Color
Get additional color on Jason Gerberry's coverage of popular stocks
2 months ago
JAZZ
3 months ago
LLY
4 months ago
TEVA
4 months ago
IONS
4 months ago
BMY
4 months ago
LLY
6 months ago
JAZZ
8 months ago
IONS
8 months ago
TEVA
9 months ago
JAZZ
a year ago
TEVA
2 years ago
AXSM
2 years ago
ACLX
2 years ago
EXEL
2 years ago
BHVN
2 years ago
RLAY
2 years ago
PCVX
2 years ago
AXSM
2 years ago
IONS
2 years ago
IONS
2 years ago
TEVA
3 years ago
ARWR
3 years ago
PCVX
3 years ago
XENE
Jason Gerberry's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Pfizer IncPFE | 5 | Hold | $26.00 | -3.88% | Maintains | a month ago |
Eli Lilly & CoLLY | 7 | Strong Buy | $1,334.00 | +8.28% | Maintains | a month ago |
Alkermes PLCALKS | 8 | Sell | $38.00 | -23.08% | Downgrades | a month ago |
Liquidia CorpLQDA | 3 | Hold | $79.00 | -13.22% | Downgrades | a month ago |
Amphastar Pharmaceuticals IncAMPH | 3 | Sell | $20.00 | -1.53% | Downgrades | a month ago |
Biohaven LtdBHVN | 3 | Sell | $11.00 | -24.35% | Downgrades | a month ago |
Jazz Pharmaceuticals PLCJAZZ | 6 | Strong Buy | $307.00 | +19.68% | Maintains | 2 months ago |
Immunovant IncIMVT | 7 | Strong Buy | $43.00 | +7.80% | Maintains | 3 months ago |
Teva Pharmaceutical Industries LtdTEVA | 12 | Strong Buy | $42.00 | +16.21% | Maintains | 4 months ago |
Ionis Pharmaceuticals IncIONS | 8 | Strong Buy | $111.00 | +94.94% | Maintains | 4 months ago |
Bristol Myers Squibb CoBMY | 5 | Strong Buy | $67.00 | +3.33% | Maintains | 4 months ago |
Lenz Therapeutics IncLENZ | 1 | Strong Buy | $29.00 | +441.04% | Maintains | 5 months ago |
Harmony Biosciences Holdings IncHRMY | 3 | Sell | $28.00 | -28.21% | Maintains | 6 months ago |
Arrowhead Pharmaceuticals IncARWR | 4 | Strong Buy | $81.00 | -8.30% | Maintains | 8 months ago |
Oculis Holding AgOCS | 4 | Strong Buy | $29.00 | +127.27% | Maintains | 9 months ago |
Axsome Therapeutics IncAXSM | 6 | Strong Buy | $176.00 | N/A | Maintains | a year ago |
Prokidney CorpPROK | 4 | Sell | $1.00 | N/A | Downgrades | a year ago |
Exelixis IncEXEL | 3 | Hold | $46.00 | N/A | Maintains | a year ago |
Vaxcyte IncPCVX | 9 | Strong Buy | $137.00 | N/A | Maintains | a year ago |
Viatris IncVTRS | 3 | Sell | $10.00 | N/A | Maintains | a year ago |
Catalyst Pharmaceuticals IncCPRX | 2 | Strong Buy | $30.00 | N/A | Reiterates | 2 years ago |
Bluebird Bio IncBLUE | 8 | Hold | $10.00 | N/A | Downgrades | 2 years ago |
Arcellx IncACLX | 5 | Strong Buy | $100.00 | N/A | Maintains | 2 years ago |
Relay Therapeutics IncRLAY | 1 | Strong Buy | $24.00 | N/A | Maintains | 2 years ago |
Intra Cellular Therapies IncITCI | 1 | Strong Buy | $91.00 | N/A | Maintains | 2 years ago |
Lakefront Biotherapeutics NvLKFT | 5 | Sell | $31.00 | N/A | Downgrades | 2 years ago |
Lyra Therapeutics IncLYRA | 3 | Strong Buy | $550.00 | N/A | Maintains | 2 years ago |
Xenon Pharmaceuticals IncXENE | 2 | Strong Buy | $56.00 | N/A | Maintains | 3 years ago |
Karuna Therapeutics IncKRTX | 2 | Strong Buy | $259.00 | N/A | Maintains | 3 years ago |
Kyntra Bio IncKYNB | 6 | Sell | $50.00 | N/A | Downgrades | 3 years ago |
Tvardi Therapeutics IncTVRD | 2 | Sell | $48.00 | N/A | Maintains | 3 years ago |
Applied Molecular Transport IncAMTI | 2 | Sell | $0.50 | N/A | Downgrades | 4 years ago |
Allogene Therapeutics IncALLO | 1 | Sell | $9.00 | N/A | Downgrades | 4 years ago |
Organon & CoOGN | 3 | Sell | $25.00 | N/A | Downgrades | 4 years ago |
Mirati Therapeutics IncMRTX | 3 | Hold | $141.00 | N/A | Upgrades | 5 years ago |
Beyondspring IncBYSI | 2 | Sell | $5.00 | N/A | Downgrades | 5 years ago |
Dice Therapeutics IncDICE | 1 | Strong Buy | $41.00 | N/A | Initiates Coverage On | 5 years ago |
Finch Therapeutics Group IncFNCH | 1 | Strong Buy | $750.00 | N/A | Initiates Coverage On | 5 years ago |
Bausch Health Companies IncBHC | 2 | Sell | $27.00 | N/A | Downgrades | 5 years ago |
Aerie Pharmaceuticals IncAERI | 2 | Sell | $9.00 | N/A | Downgrades | 6 years ago |
Coherus Oncology IncCHRS | 1 | Hold | $20.00 | N/A | Initiates Coverage On | 6 years ago |
Verrica Pharmaceuticals IncVRCA | 1 | Hold | $100.00 | N/A | Downgrades | 6 years ago |
Global Blood Therapeutics IncGBT | 1 | Strong Buy | $92.00 | N/A | Initiates Coverage On | 6 years ago |
Arena Pharmaceuticals IncARNA | 1 | Strong Buy | $56.00 | N/A | Upgrades | 6 years ago |
Horizon Therapeutics Public Ltd CoHZNP | 1 | Strong Buy | $42.00 | N/A | Maintains | 6 years ago |
Foamix Pharmaceuticals LtdFOMX | 1 | Strong Buy | $11.00 | N/A | Initiates Coverage On | 8 years ago |
Abbvie IncABBV | 3 | Strong Buy | $106.00 | N/A | Maintains | 8 years ago |
Nabriva Therapeutics PLCNBRVF | 2 | Strong Buy | $1,250.00 | N/A | Maintains | 8 years ago |
Merck & Co IncMRK | 3 | Strong Buy | $74.00 | N/A | Maintains | 8 years ago |
Allergan PLCAGN | 3 | Strong Buy | $213.00 | N/A | Maintains | 8 years ago |
Momenta Pharmaceuticals IncMNTA | 1 | Hold | N/A | N/A | Downgrades | 9 years ago |
Bioverativ IncBIVV | 1 | Buy | $56.00 | N/A | Initiates Coverage On | 9 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.